BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND CBL, RNF55, 867, ENSG00000110395, C-CBL, CBL2 AND Prognosis
20 results:

  • 1. Acute heart failure presentation, management, and outcomes in cancer patients: a national longitudinal study.
    Coles B; Welch CA; Motiwale RS; Teece L; Oliver-Williams C; Weston C; de Belder MA; Lambert PC; Rutherford MJ; Paley L; Kadam UT; Lawson CA; Deanfield J; Peake MD; McDonagh T; Sweeting MJ; Adlam D;
    Eur Heart J Acute Cardiovasc Care; 2023 May; 12(5):315-327. PubMed ID: 36888552
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Positive
    Huang S; Qi M; Tian T; Dai H; Tang Y; Huang R
    Front Endocrinol (Lausanne); 2022; 13():959089. PubMed ID: 36407316
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Pathological Stage N1 Limited-Stage Small-Cell lung cancer Patients Can Benefit From Surgical Resection.
    Yu L; Xu J; Qiao R; Han B; Zhong H; Zhong R
    Clin Lung Cancer; 2023 Jan; 24(1):e1-e8. PubMed ID: 36085281
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Treatment of severe Kaposiform lymphangiomatosis positive for NRAS mutation by MEK inhibition.
    Chowers G; Abebe-Campino G; Golan H; Vivante A; Greenberger S; Soudack M; Barkai G; Fox-Fisher I; Li D; March M; Battig MR; Hakonarson H; Adams D; Dori Y; Dagan A
    Pediatr Res; 2023 Dec; 94(6):1911-1915. PubMed ID: 35246606
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.
    Lafage-Pochitaloff M; Gerby B; Baccini V; Largeaud L; Fregona V; Prade N; Juvin PY; Jamrog L; Bories P; Hébrard S; Lagarde S; Mansat-De Mas V; Dovey OM; Yusa K; Vassiliou GS; Jansen JH; Tekath T; Rombaut D; Ameye G; Barin C; Bidet A; Boudjarane J; Collonge-Rame MA; Gervais C; Ittel A; Lefebvre C; Luquet I; Michaux L; Nadal N; Poirel HA; Radford-Weiss I; Ribourtout B; Richebourg S; Struski S; Terré C; Tigaud I; Penther D; Eclache V; Fontenay M; Broccardo C; Delabesse E
    Blood Adv; 2022 Jan; 6(2):386-398. PubMed ID: 34638130
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. KIAA0101 in Malignant Pleural Mesothelioma: A Potential Diagnostic and Prognostic Marker.
    Lin P; Zhao Y; Li X; Liang Z
    Comb Chem High Throughput Screen; 2022; 25(9):1498-1506. PubMed ID: 34238152
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Development of an immune-related gene pairs signature for predicting clinical outcome in lung adenocarcinoma.
    Wu C; Hu Q; Ma D
    Sci Rep; 2021 Feb; 11(1):3611. PubMed ID: 33574499
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Risk factors and predictors for tumor site origin in metastatic adenocarcinoma of unknown primary site.
    Li X; Shao Y; Sheng L; Zhu J; Wang Z; Guo K; Sun L
    Cancer Med; 2021 Feb; 10(3):974-988. PubMed ID: 33405390
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Systematic identification of CDC34 that functions to stabilize EGFR and promote lung carcinogenesis.
    Zhao XC; Wang GZ; Wen ZS; Zhou YC; Hu Q; Zhang B; Qu LW; Gao SH; Liu J; Ma L; Zhang YF; Zhang C; Yu H; Zhang DL; Wang M; Wang CL; Huang YC; Liu ZH; Zhao Y; Chen L; Zhou GB
    EBioMedicine; 2020 Mar; 53():102689. PubMed ID: 32114396
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. PD-L1 expression in tumor infiltrated lymphocytes predicts survival in triple-negative breast cancer.
    Wang X; Liu Y
    Pathol Res Pract; 2020 Mar; 216(3):152802. PubMed ID: 32005408
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients.
    Wei DM; Chen WJ; Meng RM; Zhao N; Zhang XY; Liao DY; Chen G
    Respir Res; 2018 Aug; 19(1):150. PubMed ID: 30103737
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Suppressed expression of cbl-b by NF-κB mediates icotinib resistance in EGFR-mutant non-small-cell lung cancer.
    Zhang T; Zheng C; Hou K; Wang J; Zhang Y; Fan Y; Zhao H; Qu X; Liu Y; Kang J; Che X; Hu X
    Cell Biol Int; 2019 Feb; 43(2):98-107. PubMed ID: 29972257
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Down-regulation of long non-coding RNA MEG3 indicates an unfavorable prognosis in non-small cell lung cancer: Evidence from the GEO database.
    Zhang Z; Liu T; Wang K; Qu X; Pang Z; Liu S; Liu Q; Du J
    Gene; 2017 Sep; 630():49-58. PubMed ID: 28782577
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma.
    Sun P; Chen C; Xia Y; Bi X; Liu P; Zhang F; Yang H; An X; Jiang W; Wang F
    Dis Markers; 2017; 2017():6570808. PubMed ID: 28676731
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.
    Schrock AB; Li SD; Frampton GM; Suh J; Braun E; Mehra R; Buck SC; Bufill JA; Peled N; Karim NA; Hsieh KC; Doria M; Knost J; Chen R; Ou SI; Ross JS; Stephens PJ; Fishkin P; Miller VA; Ali SM; Halmos B; Liu JJ
    J Thorac Oncol; 2017 Jun; 12(6):932-942. PubMed ID: 28315738
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Single Nucleotide Polymorphisms in cblB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell lung cancer.
    Li P; Wang X; Liu Z; Liu H; Xu T; Wang H; Gomez DR; Nguyen QN; Wang LE; Teng Y; Song Y; Komaki R; Welsh JW; Wei Q; Liao Z
    Clin Lung Cancer; 2016 Jul; 17(4):253-262.e5. PubMed ID: 26732495
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis.
    Yin Y; Wang J; Wang X; Gu L; Pei H; Kuai S; Zhang Y; Shang Z
    Clinics (Sao Paulo); 2015 Jul; 70(7):524-30. PubMed ID: 26222823
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The E3 ubiquitin ligase cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis.
    Zhang L; Teng Y; Fan Y; Wang Y; Li W; Shi J; Ma Y; Li C; Shi X; Qu X; Liu Y
    Oncotarget; 2015 Sep; 6(26):22918-33. PubMed ID: 26087197
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Expressions of c-cbl, cbl-b and EGFR and its role of prognosis in NSCLC].
    Jiao X; Jin B; Qu X; Yan S; Hou K; Liu Y; Hu X
    Zhongguo Fei Ai Za Zhi; 2011 Jun; 14(6):512-7. PubMed ID: 21645455
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The C-terminus of Hsp70-interacting protein promotes Met receptor degradation.
    Jang KW; Lee JE; Kim SY; Kang MW; Na MH; Lee CS; Song KS; Lim SP
    J Thorac Oncol; 2011 Apr; 6(4):679-87. PubMed ID: 21325980
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.